Promotion of Ferroptosis in Oral Cancer Cell Lines by Chrysophanol

被引:4
|
作者
Lin, Ya-Hsuan [1 ]
Chiu, Valeria [2 ]
Huang, Chun-Yen [3 ]
Tzeng, I-Shiang [4 ]
Hsieh, Po-Chun [1 ]
Kuo, Chan-Yen [4 ]
机构
[1] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Chinese Med, New Taipei, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Div Phys Med & Rehabil, New Taipei, Taiwan
[3] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan
[4] Buddhist Tzu Chi Med Fdn, Dept Res, Taipei Tzu Chi Hosp, New Taipei, Taiwan
关键词
CHOP; Chrysophanol; Ferroptosis; GPX4; LCN2; Lipid ROS production; Oral cancer; LIPOCALIN; 2; IRON;
D O I
10.37290/ctnr2641-452X.18:273-276
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Oral cancer is a type of head and neck cancer that can be life threatening if not diagnosed and treated early. Ferroptosis is a type of programmed or regulated cell death dependent on iron and reactive oxygen species but is a caspase-independent form of non-apoptotic cell death. Therefore, there is a need to identify candidate natural compound that may attenuate carcinogenesis through ferroptosis. To this end, we determined the pharmacological effects of chrysophanol on ferroptosis in two different oral cancer cell lines- FaDu, a hypopharyngeal squamous cell carcinoma and SAS, a poorly differentiated squamous cell carcinoma cell line from human tongue primary lesion. Results indicated that chrysophanol caused overproduction of lipid reactive oxygen species, decreased the level of glutathione peroxidase 4, and increased the level of lipocalin-2 and CCAAT-enhancer-binding protein homologous protein. These findings suggest that chrysophanol has the therapeutic potential to alleviate the progression of oral carcinogenesis through activation of ferroptosis.
引用
收藏
页码:273 / 276
页数:4
相关论文
共 50 条
  • [41] Inhibitory Effects of Glycerol on Growth and Invasion of Human Oral Cancer Cell Lines
    Sakurai, Satoshi
    Okada, Yasuo
    Mataga, Izumi
    JOURNAL OF HARD TISSUE BIOLOGY, 2011, 20 (01) : 37 - 45
  • [42] Iranian propolis efficiently inhibits growth of oral streptococci and cancer cell lines
    Fariba Asgharpour
    Ali Akbar Moghadamnia
    Ebrahim Zabihi
    Sohrab Kazemi
    Amirmorteza Ebrahimzadeh Namvar
    Hemmat Gholinia
    Mina Motallebnejad
    Hamid Reza Nouri
    BMC Complementary and Alternative Medicine, 19
  • [43] CHEMOSENSITIVITY OF SALIVARY-GLAND AND ORAL-CANCER CELL-LINES
    WU, JZ
    SITU, ZQ
    CHEN, JY
    LIU, B
    WANG, W
    CHINESE MEDICAL JOURNAL, 1992, 105 (12) : 1026 - 1028
  • [44] Effect of LPS on the Viability and Proliferation of Human Oral and Esophageal Cancer Cell Lines
    Goncalves, Marcia
    Cappellari, Angelica Regina
    dos Santos Junior, Andre Avelino
    Macchi, Fernanda Souza
    Antunes, Krist Helen
    Duarte de Souza, Ana Paula
    Morrone, Fernanda Bueno
    Marchi, Fernanda Olicheski
    BRAZILIAN ARCHIVES OF BIOLOGY AND TECHNOLOGY, 2016, 59
  • [45] In Vitro Anticancer Potential of Eugenol on Oral Cancer Cell Lines: A Systematic Review
    Wulan, Shafa Nafisa
    Anggraini, Jamas Ari
    Hidayat, Wahyu
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2024, 31 (05): : 10 - 31
  • [46] In Vitro Assessment of the Anticancer Potential of Evodiamine in Human Oral Cancer Cell Lines
    Sachita, Khadka
    Kim, Yongsoo
    Yu, Hyun-Ju
    Cho, Sung-Dae
    Lee, Jeong-Sang
    PHYTOTHERAPY RESEARCH, 2015, 29 (08) : 1145 - 1151
  • [47] Induction of apoptosis by parthenolide in human oral cancer cell lines and tumor xenografts
    Yu, Hyun-Ju
    Jung, Ji-Youn
    Jeong, Joseph H.
    Cho, Sung-Dae
    Lee, Jeong-Sang
    ORAL ONCOLOGY, 2015, 51 (06) : 602 - 609
  • [48] Inhibition of osteopontin expression and function in oral cancer cell lines by antisense oligonucleotides
    Muramatsu, T
    Shima, K
    Ohta, K
    Kizaki, H
    Ro, Y
    Kohno, Y
    Abiko, Y
    Shimono, M
    CANCER LETTERS, 2005, 217 (01) : 87 - 95
  • [49] Use of Contaminated/Misidentified Cell Lines: A Critical Concern for Oral Cancer Research
    Sette-de-Souza, Pedro Henrique
    Costa, Moan Jefter Fernandes
    ORAL DISEASES, 2025,
  • [50] Targeted Inhibition of CD133+ Cells in Oral Cancer Cell Lines
    Damek-Poprawa, M.
    Volgina, A.
    Korostoff, J.
    Sollecito, T. P.
    Brose, M. S.
    O'Malley, B. W., Jr.
    Akintoye, S. O.
    DiRienzo, J. M.
    JOURNAL OF DENTAL RESEARCH, 2011, 90 (05) : 638 - 645